Stocks and Investing Stocks and Investing
Tue, September 22, 2020
Mon, September 21, 2020

Michael Wiederhorn Maintained (AMED) at Buy with Increased Target to $260 on, Sep 21st, 2020


Published on 2024-10-27 13:33:19 - WOPRAI, Michael Wiederhorn
  Print publication without navigation


Michael Wiederhorn of Oppenheimer, Maintained "Amedisys, Inc." (AMED) at Buy with Increased Target from $250 to $260 on, Sep 21st, 2020.

Michael has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matt Borsch of "BMO Capital" Maintained at Hold with Increased Target to $270 on, Wednesday, September 2nd, 2020


These are the ratings of the 4 analyists that currently disagree with Michael


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Increased Target to $250 on, Thursday, July 30th, 2020
  • Frank Morgan of "RBC Capital" Maintained at Buy with Increased Target to $260 on, Thursday, July 30th, 2020
  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $255 on, Thursday, July 30th, 2020
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $260 on, Thursday, July 30th, 2020
Contributing Sources